UBS Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$46.2K 10266
2022
Q4
$46.2K Buy
+1,500
New +$46.6K ﹤0.01% 6843

Other funds holding RTO

UBS Group's RTO Position: Q2 2026 in Review

UBS Group increased its Rentokil (RTO) stake by 0.34% in Q2 2026, buying an estimated $44.6K and bringing the position to 411,162 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3265.

UBS Group first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $14.9M in Q1 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • UBS Group held 411,162 shares of Rentokil worth $11.8M as of Q2 2026.
  • UBS Group bought 1,405 Rentokil shares in Q2 2026, an estimated $44.6K.
  • Rentokil made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3265 holding.
  • UBS Group first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • UBS Group's Rentokil position peaked at $14.9M in Q1 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.